| Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
29.97 |
33.35 |
21.00 |
24.83 |
53.13 |
|
| Diluted EPS (Rs.) |
29.97 |
33.35 |
21.00 |
24.83 |
53.13 |
|
| Cash EPS (Rs.) |
35.19 |
37.70 |
28.43 |
31.92 |
61.46 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
353.55 |
336.62 |
305.75 |
292.15 |
271.80 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
353.55 |
336.62 |
305.75 |
292.15 |
271.80 |
|
| Dividend / Share(Rs.) |
0.00 |
4.50 |
3.00 |
9.00 |
4.00 |
|
| Revenue from Operations/Share (Rs.) |
188.25 |
181.70 |
218.34 |
192.65 |
270.07 |
|
| PBDIT/Share (Rs.) |
49.68 |
48.47 |
36.95 |
36.60 |
80.38 |
|
| PBIT/Share (Rs.) |
44.57 |
44.13 |
29.52 |
29.51 |
72.05 |
|
| PBT/Share (Rs.) |
40.61 |
41.01 |
27.55 |
27.95 |
71.57 |
|
| Net Profit/Share (Rs.) |
30.08 |
33.35 |
21.00 |
24.83 |
53.13 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
26.39 |
26.67 |
16.92 |
18.99 |
29.76 |
|
| PBIT Margin (%) |
23.67 |
24.28 |
13.51 |
15.31 |
26.67 |
|
| PBT Margin (%) |
21.57 |
22.57 |
12.61 |
14.50 |
26.49 |
|
| Net Profit Margin (%) |
15.97 |
18.35 |
9.61 |
12.88 |
19.67 |
|
| Return on Networth / Equity (%) |
8.50 |
9.90 |
6.86 |
8.49 |
19.54 |
|
| Return on Capital Employed (%) |
12.27 |
12.98 |
9.47 |
9.92 |
25.69 |
|
| Return on Assets (%) |
6.34 |
7.76 |
4.93 |
6.73 |
13.42 |
|
| Total Debt/Equity (X) |
0.23 |
0.14 |
0.23 |
0.11 |
0.25 |
|
| Asset Turnover Ratio (%) |
0.42 |
0.43 |
0.55 |
0.50 |
0.74 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.20 |
1.38 |
1.46 |
2.35 |
1.83 |
|
| Quick Ratio (X) |
0.83 |
0.93 |
0.84 |
1.55 |
1.12 |
|
| Inventory Turnover Ratio (X) |
4.63 |
1.77 |
1.94 |
1.41 |
1.58 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
13.49 |
35.71 |
18.12 |
7.52 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
11.93 |
26.38 |
14.10 |
6.50 |
|
| Earnings Retention Ratio (%) |
0.00 |
86.51 |
64.29 |
81.88 |
92.48 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
88.07 |
73.62 |
85.90 |
93.50 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
71,682.11 |
66,554.38 |
34,360.05 |
40,961.62 |
55,216.93 |
|
| EV/Net Operating Revenue (X) |
6.56 |
6.25 |
2.69 |
3.63 |
3.49 |
|
| EV/EBITDA (X) |
24.84 |
23.43 |
15.87 |
19.10 |
11.72 |
|
| MarketCap/Net Operating Revenue (X) |
6.16 |
6.00 |
2.37 |
3.47 |
3.26 |
|
| Retention Ratios (%) |
0.00 |
86.50 |
64.28 |
81.87 |
92.47 |
|
| Price/BV (X) |
3.28 |
3.24 |
1.69 |
2.29 |
3.24 |
|
| Price/Net Operating Revenue |
6.16 |
6.00 |
2.37 |
3.47 |
3.26 |
|
| Earnings Yield |
0.03 |
0.03 |
0.04 |
0.04 |
0.06 |
|
Source : Dion Global Solutions Limited
